Corundum Group’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $837K | Buy |
10,694
+381
| +4% | +$30.7K | 0.25% | 67 |
|
|
2026
Q1 | $894K | Buy |
10,313
+2,140
| +26% | +$205K | 0.3% | 64 |
|
|
2025
Q4 | $785K | Sell |
8,173
-254
| -3% | -$24.7K | 0.26% | 61 |
|
|
2025
Q3 | $803K | Buy |
8,427
+68
| +0.8% | +$6.25K | 0.33% | 60 |
|
|
2025
Q2 | $729K | Buy |
8,359
+328
| +4% | +$27.8K | 0.32% | 61 |
|
|
2025
Q1 | $722K | Sell |
8,031
-7,996
| -50% | -$716K | 0.35% | 62 |
|
|
2024
Q4 | $1.28M | Buy |
16,027
+8,237
| +106% | +$713K | 0.48% | 59 |
|
|
2024
Q3 | $701K | Sell |
7,790
-2,778
| -26% | -$234K | 0.32% | 63 |
|
|
2024
Q2 | $832K | Buy |
10,568
+4,931
| +87% | +$404K | 0.33% | 68 |
|
|
2024
Q1 | $491K | Buy |
+5,637
| New | +$481K | 0.24% | 70 |
|
|
2023
Q4 | – | Sell |
-9,452
| Closed | -$741K | – | 105 |
|
|
2023
Q3 | $741K | Sell |
9,452
-516
| -5% | -$43.2K | 0.42% | 54 |
|
|
2023
Q2 | $878K | Sell |
9,968
-5,022
| -34% | -$432K | 0.44% | 57 |
|
|
2023
Q1 | $1.21M | Buy |
14,990
+4,894
| +48% | +$399K | 0.57% | 52 |
|
|
2022
Q4 | $785K | Buy |
10,096
+1,004
| +11% | +$81.4K | 0.44% | 62 |
|
|
2022
Q3 | $734K | Buy |
9,092
+2,005
| +28% | +$180K | 0.46% | 54 |
|
|
2022
Q2 | $636K | Buy |
7,087
+681
| +11% | +$69K | 0.43% | 63 |
|
|
2022
Q1 | $711K | Buy |
6,406
+2,960
| +86% | +$313K | 0.66% | 59 |
|
|
2021
Q4 | $356K | Buy |
3,446
+1,161
| +51% | +$134K | 0.23% | 78 |
|
|
2021
Q3 | $286K | Sell |
2,285
-134
| -6% | -$17.3K | 0.21% | 80 |
|
|
2021
Q2 | $300K | Buy |
2,419
+108
| +5% | +$13.6K | 0.2% | 76 |
|
|
2021
Q1 | $273K | Buy |
2,311
+80
| +4% | +$9.38K | 0.21% | 73 |
|
|
2020
Q4 | $261K | Buy |
2,231
+64
| +3% | +$7.04K | 0.22% | 72 |
|
|
2020
Q3 | $225K | Buy |
+2,167
| New | +$218K | 0.22% | 73 |
|
|
2020
Q2 | – | Sell |
-2,262
| Closed | -$204K | – | 64 |
|
|
2020
Q1 | $204K | Sell |
2,262
-83
| -4% | -$8.83K | 0.29% | 53 |
|
|
2019
Q4 | $266K | Buy |
2,345
+73
| +3% | +$8.01K | 0.28% | 55 |
|
|
2019
Q3 | $247K | Sell |
2,272
-2
| -0.1% | -$209 | 0.29% | 52 |
|
|
2019
Q2 | $221K | Buy |
2,274
+19
| +0.8% | +$1.74K | 0.25% | 58 |
|
|
2019
Q1 | $205K | Sell |
2,255
-4,363
| -66% | -$390K | 0.23% | 65 |
|
|
2018
Q4 | $602K | Buy |
+6,618
| New | +$618K | 0.55% | 39 |
|
Other funds holding MDT
Corundum Group's MDT Position: Q2 2026 in Review
Corundum Group increased its Medtronic (MDT) stake by 3.7% in Q2 2026, buying an estimated $30.7K and bringing the position to 10,694 shares worth $837K. The position accounts for 0.25% of the portfolio, ranked #67.
Corundum Group first reported a position in MDT in Q4 2018 and has held it in 29 quarters since. The position peaked at $1.28M in Q4 2024. 2,134 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- Corundum Group held 10,694 shares of Medtronic worth $837K as of Q2 2026.
- Corundum Group bought 381 Medtronic shares in Q2 2026, an estimated $30.7K.
- Medtronic made up 0.25% of Corundum Group's portfolio in Q2 2026, its #67 holding.
- Corundum Group first reported a position in Medtronic in Q4 2018 and has held it in 29 quarters since.
- Corundum Group's Medtronic position peaked at $1.28M in Q4 2024.
- 2,134 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on Corundum Group's 13F filing for Q2 2026, filed 7 Aug 2026.